MiMark diagnostics

📢 Exciting News! 📢 We’re thrilled to share that  Javier Carvajal Rodríguez  is currently in London attending  the BenchTalk 2024 ! This event is a fantastic opportunity for Javier to dive deep into the latest trends, tools, and insights in Benchling, an essential tool for MiMARK, and we’re excited to see what he will bring back to the team. 💡 We do not doubt that it will be a valuable learning experience, filled with innovative ideas and opportunities for growth. If you're attending Benchtalk, make sure to connect with Javier!

Exciting News from the International Gynecologic Cancer Society (IGCS)! 🌟 The IGCS congress in Dublin has kicked off, and we are thrilled to share that MiMARK is attending, with our Clinical Manager Roger Canton Alberich representing us on-site! As a global leader in advancing care for women with gynecologic cancers, IGCS is committed to enhancing patient outcomes through groundbreaking research, education, and public awareness. ✨ Highlights: Global Collaboration: Bringing together experts from all over the world to share the latest advancements in gynecologic cancer care. Innovative Diagnostics: Leading the way in early detection and accurate diagnosis of gynecologic cancers. Patient-Centered Care: At the heart of this congress is the powerful voice of women and patients. Their experiences are shaping the future of diagnostics and treatment—reminding us that effective healthcare solutions listen to and prioritize the needs and insights of those affected.   Education & Training: Empowering healthcare professionals with the knowledge and skills to make a difference. We at MiMARK are excited to be part of this incredible event and share it with stakeholders who have the same mission of improving gynecological cancer care. Together, we can drive real, positive change! 💪 #IGCS #GynecologicCancer #HealthcareInnovation #PatientVoices #GlobalHealth #MiMARK #Diagnostics #WomensHealth

We're honored to share that MiMARK was recognized at the Gender Gap in Investments event in Brussels, where we were awarded for the Best Pitch! 🎤 🏆 Heartfelt congratulations to our Innovation Manager, Cristina Vilarmau Marsinyach, whose dedication and expert presentation of our advancements in gynecological diagnostics truly made a difference. This important event, supported by the European Parliament and European Innovation Council and SMEs Executive Agency (EISMEA), focused on nurturing equitable investment opportunities, and we are grateful to have been part of such a meaningful dialogue. A big thank you to all participants and organizers. We are inspired to keep working towards more inclusive and supportive industry practices! #GenderEquality #Innovation #EICAccelerator

🌟 Our News from Chicago! 🌟 Before the summer break, the MiMARK team has traveled to Chicago to attend both the #ADLM2024 (formerly known as AACC) and the #DxPx US Investor & Industry Partnering Conference in Chicago! Our dynamic duo, Marina Rigau  and Cristina Vilarmau Marsinyach are on the ground, eager to dive into the latest advancements in diagnostics. At ADLM, we'll explore groundbreaking innovations in clinical laboratory science, network with industry leaders, and discover new technologies shaping diagnostics' future, like us! At the DxPx Conference, we look forward to strategic partnering opportunities, investor meetings, and collaborations that drive innovation in the Diagnostics sector. This is our first time attending these prestigious events, and we can't wait to learn, connect, and innovate! We are excited to engage with fellow professionals and forge new partnerships. If you're attending, let's connect and meet! 👉 ADLM Meeting 👉 DxPx Conference #MiMark #ADLM2024 #DxPx2024 #Diagnostics #Innovation #Healthcare #Networking #Chicago #MedicalConference #Partnerships

➡ Do you prefer the mountains or the beach?   After countless lunchtime debates about our dream getaways, it's finally time to make those plans a reality! Most of our team is taking a short break this summer to enjoy a well-deserved rest. We’re excited to recharge and come back with fresh ideas and renewed energy. Wishing everyone a fantastic summer break, filled with relaxation and fun! See you all soon, we will be back ready to tackle new challenges. 🌞🏖️🏔️ #SummerBreak #TeamRest #Recharge #MiMARK

🌿 What a fantastic day at Zizinia de les Flors! Yesterday, the MiMark team stepped out of the office and into the world of #fermentation. 🥣 From hands-on activities in making our own fermented products to enjoying a meal prepared right at Zizinia, we not only learned about the fermentation process but also about the importance of patience and precision—qualities that resonate deeply with our work in diagnostics. 🌱 At MiMark, we believe in nurturing our team’s growth both professionally and personally. Today was all about expanding horizons, exploring new skills, and continuing to cultivate a culture of continuous learning and well-being. A big thank you to Zizinia de les Flors for hosting us! #MiMark #TeamBuilding #EmployeeEngagement #ProfessionalDevelopment #FermentationWorkshop

🌟 Exciting News from MiMark! 🌟 We're honored to share that MiMARK has been selected as the winning solution at the #e_llasPitchDay. Marina Rigau (CEO) and Cristina Vilarmau Marsinyach (Innovation Manager) presented our approach based on the use of gynecological fluids to address endometrial cancer diagnosis, which resonated very well with the jury. The whole team’s hard work and dedication have been key to this recognition. We are looking forward to collaborating within the hub and GSK, and learning more as we develop our solution further. 🔗 Read more about the event and other participants here. We appreciate the support from the European Commission through the #HorizonEurope programme (HORIZON-EIC-2023-ACCELERATOR-01) for the support in the development of WomEC and everyone at the e-llas innovation hub. #HealthcareInnovation #WomenInTech #EndometrialCancer #MiMARK #WomEC #e_llas #EICAccelerator

🌟 Exciting News! 🌟 We are happy to announce the incorporation of Lola Fernández Encinas and Leandro Radusky into our team at MiMARK! Lola brings a wealth of experience in developing immunoassays for diagnostic purposes, Her incorporation will be instrumental in our efforts to validate WomEC, and also will provide support for our upcoming projects. Leandro has an impressive background in data science applied to the biomedical field, and his expertise in bioinformatics will be invaluable as we continue to grow and innovate. Welcome to the MiMARK family, Lola and Leandro! 🚀

June is Endometrial Cancer Awareness Month. Join us in raising awareness Endometrial cancer (EC) is a hot topic in research. It is the most common gynecological cancer in high-income countries, with an incidence projected to be a 46% higher by 2040. This makes it a pressing need to understand better the disease, and to find ways to treat and detect it early. During 2023, 90 studies related to EC were initiated. The studies ranged from evaluating new medications for treating EC to developing less invasive diagnostic methods for early detection. All the efforts shared a common concern: finding effective solutions for managing and overcoming EC. Patients who participate in these trials play a vital role, offering their time and health to advance knowledge and improve future care. Their trust drives research forward, making better treatments and simpler diagnostic methods available to the next generations. #EndometrialCancerAwareness #ECAwareness #WomensHealth #CancerDiagnosis #GynecologicalCancer #ECMonth #FightEC #Innovation #MiMARK

June is Endometrial Cancer Awareness Month. Join us in raising awareness What is the state of art of Endometrial Cancer? Endometrial cancer (EC) is a complex, heterogeneous condition. It's not just one disease but a family of disorders, each with varying severity and outcomes. Traditionally, EC was classified based on surgical findings, but today, molecular and genetic insights give us a deeper understanding.  The criteria for staging EC have recently been updated to include these insights, redefining the classification.  These advancements allow physicians to better understand the disease, obtaining a more accurate prognosis and better guiding the most effective treatments for each case. These findings mark a new era for innovation in diagnostics. With the discovery of biomarkers that can detect and stage EC with more precision, we enter a new era in personalized medicine. The hope is that these advancements will lead to earlier detection, more effective treatments, and improved outcomes for women diagnosed with EC. #EndometrialCancerAwareness #ECAwareness #WomensHealth #CancerDiagnosis #GynecologicalCancer #ECMonth #FightEC #Innovation #MiMARK